Nursing care
H. pylori eradication: multi-drug regimens, adherence and test of cure
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated October 2026
Short answer
H. pylori is treated with several drugs at once, usually an acid suppressant plus two or more antibiotics, often with bismuth, for around two weeks. Resistance and missed doses cause treatment failure, so adherence teaching is central. Nurses explain harmless dark stools from bismuth, alcohol avoidance with metronidazole, and the need for a later test to confirm cure.
Why eradication uses several drugs at once
H. pylori lives in the stomach lining and resists single antibiotics. Regimens combine a proton pump inhibitor, which raises gastric pH and helps antibiotics work, with two or more antimicrobials. Bismuth quadruple therapy uses a proton pump inhibitor, bismuth, metronidazole and tetracycline, and is preferred where clarithromycin resistance is common.
Clarithromycin-based triple therapy remains an option where resistance is low, and other combinations, such as rifabutin-based or vonoprazan-based regimens, are used for resistant infections. The prescriber chooses the regimen; the nurse's job is to make a complicated schedule workable, because a regimen that is only partly taken is likely to fail and can promote resistance.
Adherence to the full course
Regimens commonly run for 14 days with several tablets taken up to four times a day. Symptoms may settle within days, and side effects such as nausea, diarrhoea or a metallic taste tempt people to stop early. Explain that feeling better does not mean the infection is gone and that incomplete treatment risks failure.
Practical help works better than warnings. Lay out a written timetable that fits meals and sleep, suggest a pill organiser or phone reminders, and check whether combination packs are available. Ask the patient to describe what they will do if they miss a dose or vomit, and to contact the team rather than quietly stop.
Combination therapy also means more chances for interactions. Ask about every prescription, over-the-counter product and supplement before the first dose, and check allergy history carefully, since regimens may contain amoxicillin or tetracycline. A patient with a penicillin allergy needs this flagged to the prescriber before treatment starts, because it changes which regimen is suitable.
Expected effects and drug-specific teaching
Bismuth commonly darkens the stool and tongue. This is expected and harmless, and patients should be told in advance so they do not stop treatment out of alarm. Black stools can also signal upper GI bleeding, so ask about other features such as dizziness, vomiting blood, sticky tarry stool or pain, and report those.
Metronidazole interacts with alcohol: drinking during treatment and for at least three days after the last dose can cause flushing, nausea, vomiting, cramps and headache. It can also cause a metallic taste, and numbness or tingling in the hands or feet, seizures, confusion or poor coordination need urgent review. Ask about all other medicines before starting.
Test of cure and what happens if it fails
Eradication is confirmed with a urea breath test, stool antigen test or endoscopy taken at least four weeks after finishing therapy. Proton pump inhibitors and recent antibiotics can cause false-negative results, so patients are usually asked to stop the acid suppressant for a period before the test, as directed by the team.
Teach patients why the test matters even when they feel well, and explain the preparation clearly. If symptoms return or the test is positive, a different regimen is usually chosen, often avoiding antibiotics already used. Accurate history of what was taken and how completely helps the prescriber select the next option.
Worked scenario: black stools on day three
A hypothetical patient on bismuth quadruple therapy phones on day three, worried because their stool has turned black and their tongue looks dark. They feel well, with no dizziness or vomiting. Options are to tell them to stop all medicines and attend the emergency department, to reassure and continue, or to assess further.
Brief assessment then reassurance is best. Dark stool and tongue are expected with bismuth, and the absence of dizziness, vomiting blood, weakness or abdominal pain makes bleeding less likely. Stopping treatment would risk failure. The nurse documents the call and explains which red-flag symptoms would change the plan.
Sources and further reading
MSD Manual Professional: Helicobacter pylori infection. Bismuth quadruple and triple regimens, resistance, alternatives, test of cure timing and bismuth stool and tongue darkening.
MedlinePlus: Metronidazole. Alcohol avoidance during and after treatment, metallic taste and neurological warning signs.
NHS: Stomach ulcer treatment. Antibiotics plus acid-reducing medicine for H. pylori and testing after treatment.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our gastrointestinal practice questions are the closest set to what this page covers.
Common questions
Why does H. pylori treatment include a proton pump inhibitor?
Reducing stomach acid helps the antibiotics work and helps the ulcer heal. The acid suppressant is part of the regimen, not an optional extra.
How long after metronidazole should a patient avoid alcohol?
MedlinePlus advises avoiding alcohol and products containing alcohol or propylene glycol during treatment and for at least three days after the last dose.
When is the test of cure done?
At least four weeks after finishing treatment, using a breath test, stool antigen test or endoscopy. Acid suppressants are usually stopped beforehand to avoid a false-negative result.